| Literature DB >> 26252212 |
John Haskew1, Gunnar Rø2, Kenrick Turner3, Davies Kimanga4, Martin Sirengo5, Shahnaaz Sharif6.
Abstract
BACKGROUND: Electronic medical record (EMR) systems are increasingly being adopted to support the delivery of health care in developing countries and their implementation can help to strengthen pathways of care and close gaps in the HIV treatment cascade by improving access to and use of data to inform clinical and public health decision-making.Entities:
Mesh:
Year: 2015 PMID: 26252212 PMCID: PMC4529204 DOI: 10.1371/journal.pone.0135361
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Demographic and clinical variables of active patients registered in the EMR system pre- and post-intervention.
| Pre-intervention N. (%) | Post-intervention N. (%) | |
|---|---|---|
|
| 4,544 (100.0%) | 4,344 (100.0%) |
|
| ||
| <15years | 412 (9.1%) | 387 (8.9%) |
| 15-24years | 188 (4.1%) | 223 (5.1%) |
| 25-34years | 1,011 (22.3%) | 918 (21.1%) |
| 35-44years | 1,464 (32.2%) | 1,402 (32.3%) |
| 45-54years | 930 (20.5%) | 936 (21.6%) |
| 55-64years | 406 (8.9%) | 399 (9.2%) |
| >65years | 91 (2.0%) | 78 (1.8%) |
| Missing | 42 (0.9%) | 1 (0.02%) |
|
| ||
| Male | 1,606 (35.3%) | 1,489 (34.3%) |
| Female | 2,894 (63.7%) | 2,854 (65.7%) |
| Missing | 44 (1.0%) | 1 (0.02%) |
|
| ||
| VCT | 2,313 (50.9%) | 2,241 (51.6%) |
| Outpatient | 197 (4.3%) | 301 (6.9%) |
| MCH-ChildClinic | 5 (0.1%) | 14 (0.3%) |
| PMTCT | 225 (5.0%) | 281 (6.5%) |
| Inpatient | 295 (6.5%) | 249 (5.7%) |
| TBclinic | 113 (2.5%) | 111 (2.6%) |
| Unknown | 19 (0.4%) | 187 (4.3%) |
| Other | 1,002 (22.1%) | 891 (20.5%) |
| Missing | 375 (8.3%) | 69 (1.6%) |
|
| ||
| ≤350cells/μl | 2,219 (48.8%) | 2,435 (56.1%) |
| >350cells/μl | 1,499 (33.0%) | 1,555 (35.8%) |
| missing | 826 (18.2%) | 354 (8.2%) |
|
| ||
| WHOStage1 | 707 (15.6%) | 1,202 (27.7%) |
| WHOStage2 | 955 (21.0%) | 1,601 (36.9%) |
| WHOStage3 | 585 (12.9%) | 977 (22.5%) |
| WHOStage4 | 39 (0.9%) | 85 (2.0%) |
| Missing | 2,258 (49.7%) | 479 (11.0%) |
|
| ||
| EligibleandonART | 2,127 (46.8%) | 3,129 (72.0%) |
| EligiblebutnotonART | 1,346 (29.6%) | 270 (6.2%) |
| NoteligibleandnotonARTorMissing | 1,071 (23.6%) | 945 (21.8%) |
* patients eligible for ART, based on CD4 or WHO stage, but who have not started ART
Missing demographic and clinical variables of active patients registered in the EMR system pre- and post-intervention.
| Missing Data | Pre N. (%) | Post N. (%) | % diff | 95% CI | P |
|---|---|---|---|---|---|
| Age | 42 (0.9) | 1 (0.02) | -0.9% | 0.6–1.2 | <0.001 |
| Gender | 44 (1.0) | 1 (0.02) | -0.9% | 0.6–1.2 | <0.001 |
| Patient Source | 375 (8.3) | 69 (1.6) | -6.6% | 5.7–7.5 | <0.001 |
| First CD4 | 826 (18.2) | 354 (8.2) | -10.0% | 8.6–11.4 | <0.001 |
| First WHO clinical stage | 2,258 (49.7) | 479 (11.0) | -38.7% | 36.9–40.4 | <0.001 |
| Total | 2,619 (57.6) | 764 (17.6) | -40.0% | 38.2–41.8 | <0.001 |
* Two-sample test of proportions
** Patient records missing either age, gender, patient source, first CD4 or first WHO clinical stage data variables
Patients eligible but not on ART and patients followed up following a missed clinic appointment pre- and post-intervention.
| Variable | Pre N. (%) | Post N. (%) | % diff | 95% CI | P |
|---|---|---|---|---|---|
| Eligible but not on ART | 1,346 (29.6%) | 270 (6.2%) | -23.4% | 21.9–24.9 | <0.001 |
| Patient follow-up | 1 (0.02%) | 656 (15.1%) | +15.1% | 14.0–16.1 | <0.001 |
* Two-sample test of proportions
** patients eligible for ART, based on CD4 count ≤350 cells/μl or WHO clinical stage 3 or 4, but who have not yet started ART
*** patients who have missed next appointment date by more than two weeks (as % of patients registered)